C
CGON icon

Covestor’s CG Oncology CGON Stock Holding History

Covestor’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21K Sell
314
-35
-10% -$1.98K 0.01% 1080
2025
Q4 		$14K Sell
349
-116
-25% -$4.8K 0.01% 1424
2025
Q3 		$19K Sell
465
-4
-0.9% -$116 0.01% 1282
2025
Q2 		$12K Buy
469
+465
+11,625% +$11.2K 0.01% 1455
2025
Q1 		$0 Hold
4
– – ﹤0.01% 2270
2024
Q4 		$0 Hold
4
– – ﹤0.01% 2278
2024
Q3 		$0 Hold
4
– – ﹤0.01% 2266
2024
Q2 		$0 Buy
+4
New +$139 ﹤0.01% 2276

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Covestor's CGON Position: Q1 2026 in Review

Covestor reduced its CG Oncology (CGON) stake by 10% in Q1 2026, selling an estimated $1.98K and leaving 314 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #1080.

Covestor first reported a position in CGON in Q2 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Covestor held 314 shares of CG Oncology worth $21K as of Q1 2026.
  • Covestor sold 35 CG Oncology shares in Q1 2026, an estimated $1.98K.
  • CG Oncology made up 0.01% of Covestor's portfolio in Q1 2026, its #1080 holding.
  • Covestor first reported a position in CG Oncology in Q2 2024 and has held it in 8 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.